skip navigation

Add your conference to our Justice Events calendar


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Library collection. To conduct further searches of the collection, visit the NCJRS Abstracts Database. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.

  NCJ Number: NCJ 217269     Find in a Library
  Title: Evaluation of Prescription Drug Monitoring Programs
  Document URL: PDF 
  Agency Summary: Agency Summary 
  Author(s): Ronald Simeone ; Lynn Holland
  Corporate Author: Simeone Associates, Inc.
United States of America
  Date Published: 09/2006
  Page Count: 46
  Annotation: This study examined the direct and indirect effects of Prescription Drug Monitoring Programs (PDMPs) on the supply and abuse of prescription drugs.
  Abstract: Study findings suggest that the presence of a Prescription Drug Monitoring Program (PDMP) reduces per capita supply of prescription pain relievers and stimulants which in turn reduces the probability of abuse for such drugs. The results also suggest that States which are proactive in their approach to regulation may be more effective in reducing the per capita supply of prescription pain relievers and stimulants than States which are reactive in their approach to regulation. In conclusion, the results from the aggregate and individual response models indicate that PDMPs inhibited growth in prescription sales for pain relievers and stimulants, and in doing so, exerted an indirect effect on the probability of abuse for these drugs. The introduction of measures of price per gram for pure heroin, cocaine, crack, and methamphetamine in the model would be instructive, and an examination of possible substitution effects in greater detail. Twenty States have implemented systems to monitor the prescription and sale of drugs identified as controlled substances by the Drug Enforcement Administration (DEA), and 23 States are in the process of designing or planning to design such systems. PDMPs are all intended ultimately to reduce the abuse of controlled pharmaceutical substances. Tables, figures, and references
  Main Term(s): Prescription drugs
  Index Term(s): Drug abuse ; Drug regulation ; Drug law enforcement ; Controlled Substances ; Illegal dispensing of licit drugs ; Pharmacy crimes ; BJA grant-related documents
  Sponsoring Agency: Bureau of Justice Assistance
US Dept of Justice
Office of Justice Programs
United States of America
  Grant Number: 2005-PM-BX-K189
  Sale Source: Simeone Associates, Inc.
220 Lancaster Street
Albany, NY 12210-1132
United States of America
  Type: Program/Project Evaluation
  Country: United States of America
  Language: English
  Note: Downloaded on February 6, 2007.
  To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.